Schedule 13G ownership disclosure

Kitov Pharmaceuticals Holdings Ltd.

Security class unavailable · CUSIP: 49803V107

Event date: 2015-11-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-15-003744
Form type
SC 13G
Filer
PURPLE BIOTECH LTD.
CIK
CIK 1614744
Filed
Dec 17, 2015
Reporting period
Nov 25, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub